ACG: No Cancer Risk With Biologic in Crohn’s (CME/CE)
WASHINGTON (MedPage Today) — Patients with Crohn’s disease who are taking infliximab don’t have a higher cancer rate than those on other therapies, a researcher said here.
WASHINGTON (MedPage Today) — Patients with Crohn’s disease who are taking infliximab don’t have a higher cancer rate than those on other therapies, a researcher said here.
Comments are closed.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information: verify here.